• Gilenya® (Fingolimod)

    Indication Gilenya is indicated as disease-modifying monotherapy in highly active relapsing-remitting multiple sclerosis (RRMS) in the following groups of adult and paediatric patients aged 10 years and older: • patients with highly active disease...

  • Entresto® (sacubitril/valsartan)

    Indication Heart Failure Entresto® is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection...

  • Jakavi® (ruxolitinib)

    JAKAVI (ruxolitinib) JAKAVI (ruxolitinib) is the only licensed oral JAK1 and JAK2 inhibitor targeted therapy approved to treat adult patients with myelofibrosis (MF). 1 Indications: Myelofibrosis (MF) JAKAVI® (ruxolitinib) is indicated for the treatment...

  • Exjade® FCT (deferasirox)

    Exjade® FCT is indicated for Treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in adult and pediatric patients (aged 2 years and over) 1 . Treatment of chronic iron overload in patients with non-transfusion-...

  • Certican® (everolimus)

    Certican is a selective immunosuppressive agent. Indications Kidney and heart transplantation Certican is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac...

  • Xolair® (omalizumab)

    Allergy Asthma Children 6 to < 12 years of age Xolair is indicated as add-on therapy to improve asthma control with severe persistent allergic asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and frequent daytime...

  • Exforge® (valsartan/amlodipine)

    EXFORGE ® IS AVAILABLE IN THREE CONVENIENT DOSAGES IN MALAYSIA. About Exforge® Exforge ® is indicated for treatment of essential hypertension, in patients whose blood pressure is not adequately controlled by monotherapy. It is also indicated for the...

  • Patient support material

    Access support materials for your patients treated with EXJADE® FCT.

    EXJADE® FCT patient...

  • Terms of use

    1. Acceptance Your access to and use of this Site is subject to the following terms and conditions and all applicable laws. By accessing and browsing this Site, you accept, without limitation or qualification, these Terms and Conditions and acknowledge...

  • Healthcare Professional Resources

    Counselling Tool

    In many healthcare systems, healthcare professionals are the primary source of direct care for patients. At Novartis, we are committed to support the consultation process between patients and healthcare professionals.

    You may...

page 

Pages

 of  4
×

Ask Speakers

×

Medical Information Request